SYNNEX ($SNX) is expected to release its quarterly earnings data on Thursday, September 25th before market open, per Finnhub. Analysts are expecting revenue of $15,262,447,451 and earnings of $3.07 per share.
You can see Quiver Quantitative's $SNX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
SYNNEX Insider Trading Activity
SYNNEX insiders have traded $SNX stock on the open market 32 times in the past 6 months. Of those trades, 0 have been purchases and 32 have been sales.
Here’s a breakdown of recent trading of $SNX stock by insiders over the last 6 months:
- RICHARD T HUME has made 0 purchases and 6 sales selling 63,310 shares for an estimated $8,624,466.
- DENNIS POLK (Hyve Solutions Executive) has made 0 purchases and 17 sales selling 32,250 shares for an estimated $4,263,049.
- MARSHALL WITT (Chief Financial Officer) has made 0 purchases and 6 sales selling 4,093 shares for an estimated $571,345.
- MIRIAM ANNE MURPHY (President, Europe) sold 3,000 shares for an estimated $330,000
- ALIM DHANJI (Chief Human Resources Officer) sold 1,257 shares for an estimated $179,009
- ANN F VEZINA sold 812 shares for an estimated $122,141
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SYNNEX Hedge Fund Activity
We have seen 218 institutional investors add shares of SYNNEX stock to their portfolio, and 313 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- METROPOLIS CAPITAL LTD added 848,699 shares (+inf%) to their portfolio in Q2 2025, for an estimated $115,168,454
- VANGUARD GROUP INC added 759,022 shares (+10.1%) to their portfolio in Q2 2025, for an estimated $102,999,285
- AQR CAPITAL MANAGEMENT LLC removed 618,227 shares (-63.2%) from their portfolio in Q2 2025, for an estimated $83,893,403
- THRIVENT FINANCIAL FOR LUTHERANS removed 572,729 shares (-94.9%) from their portfolio in Q2 2025, for an estimated $77,719,325
- DIMENSIONAL FUND ADVISORS LP added 525,027 shares (+23.5%) to their portfolio in Q2 2025, for an estimated $71,246,163
- JONES FINANCIAL COMPANIES LLLP removed 498,926 shares (-99.9%) from their portfolio in Q2 2025, for an estimated $67,704,258
- CITADEL ADVISORS LLC added 453,155 shares (+90.6%) to their portfolio in Q2 2025, for an estimated $61,493,133
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SYNNEX Analyst Ratings
Wall Street analysts have issued reports on $SNX in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 09/23/2025
- Morgan Stanley issued a "Overweight" rating on 09/18/2025
- B of A Securities issued a "Buy" rating on 07/24/2025
- Loop Capital issued a "Buy" rating on 06/30/2025
- RBC Capital issued a "Outperform" rating on 04/11/2025
- CFRA issued a "Buy" rating on 03/28/2025
- Goldman Sachs issued a "Buy" rating on 03/28/2025
To track analyst ratings and price targets for SYNNEX, check out Quiver Quantitative's $SNX forecast page.
SYNNEX Price Targets
Multiple analysts have issued price targets for $SNX recently. We have seen 10 analysts offer price targets for $SNX in the last 6 months, with a median target of $158.0.
Here are some recent targets:
- Vincent Colicchio from Barrington Research set a target price of $156.0 on 09/23/2025
- Erik Woodring from Morgan Stanley set a target price of $173.0 on 09/18/2025
- Ashish Sabadra from RBC Capital set a target price of $165.0 on 08/22/2025
- Ruplu Bhattacharya from B of A Securities set a target price of $170.0 on 07/24/2025
- Joseph Cardoso from JP Morgan set a target price of $160.0 on 07/17/2025
- Ananda Baruah from Loop Capital set a target price of $160.0 on 06/30/2025
- Shreya Gheewala from CFRA set a target price of $132.0 on 03/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
